Blog Archives

“Trust Is the Coin of the Realm.” Investors Sue Biopharmaceutical Founder for Securities Fraud.

Court finds investors allegations plausibly suggest that founder knew that a statement he made to investors that its flagship pain product held the “highest” commercial potential in terms of profitability was not true.  M&A Stories July 29, 2021 Introduction There

Posted in federal securities fraud, scienter, stock purchase agreement, tying fraud to economic loss

Recent Comments